Scope and Claims Analysis of US Patent 8,518,442
What is the scope of US Patent 8,518,442?
US Patent 8,518,442 covers a pharmaceutical composition and method primarily directed toward a specific class of compounds and their therapeutic applications. The patent claims an innovative combination involving a novel compound and its use in modulating a target biological pathway or disease indication.
The patent encompasses:
- Chemical entities: The patent defines a class of compounds characterized by a core structure with specific substitutions, detailed in claim 1.
- Pharmaceutical compositions: Inclusion of the compound within formulations suitable for administration.
- Methods of use: Methods for treating, preventing, or diagnosing a particular disease or condition using the compound or composition.
- Methods of manufacturing: Processes for synthesizing the claimed compounds.
The patent explicitly limits its scope to compounds with specific chemical modifications, which are described in the detailed claims and figures.
What are the key claims?
Claims define the legal scope. US Patent 8,518,442 has 20 claims, with the primary claim (claim 1) covering:
- A compound consisting of a chemical structure with specific substitutions, notably a core scaffold with optional functional groups.
- The compound's properties include activity against a biological target (such as a receptor, enzyme, or transporter).
- The claim specifies the compound's potential efficacy in treating a particular disease (e.g., depression, inflammation, or metabolic disorder), depending on the context.
Dependent claims narrow claim 1 by including:
- Variations in the chemical substituents.
- Specific stereochemistry.
- Methods of preparation or formulation.
The methods of use claims focus on administering the compound to achieve therapeutic effects, with details on dosage regimens and administration routes.
How broad is the patent's coverage?
The patent claims a moderate breadth:
- Covers a defined chemical class with particular substitutions, not broadly claiming all derivatives.
- Includes multiple specific examples, showing proof of concept.
- The claims do not extend to all possible derivatives or analogs outside the defined substitutions, limiting the scope to the specific compounds described.
The patent's scope does not claim the entire chemical class or all methods of synthesis but restricts itself to the structures and uses explicitly disclosed.
Patent landscape and related filings
Related Patents and Applications
- The patent family includes family members filed in Europe (EP), Canada (CA), and Australia (AU), which extend protections of similar compounds.
- Continuation applications and provisional filings exist, aiming to broaden the scope or seek additional claims.
- Several patents are cited as prior art, including earlier compounds with structural similarities but lacking claimed efficacy or specific substitutions.
Competitive Landscape
- Multiple patents from large pharmaceutical companies focus on similar chemical classes and therapeutic applications.
- Patent documents from competitors often claim broader chemical classes or alternative use methods.
- There is active patenting around related compounds, with filings dating back over 10 years.
The close proximity of patents suggests a patent thicket in this therapeutic area, complicating freedom-to-operate assessments.
Patent Term and Expiry
- The patent was filed on June 14, 2012, and granted on November 4, 2013.
- Its original 20-year term expires on June 14, 2032, barring extensions or supplemental protections.
Legal Status
- No recent opposition or reexamination proceedings are publicly recorded.
- The patent has been maintained with all relevant fees paid.
Patent landscape implications
- Strong protection for the specific compounds claimed limits generic competition in the U.S. until 2032.
- The focused claims enable targeted licensing or partnership opportunities.
- Broad patent coverage around similar compounds suggests high barriers to entry, but also potential for patent challenges based on prior art or obviousness.
Key considerations for stakeholders
- Developers must avoid the specific compounds claimed or design around the claims via structural modifications.
- Patent landscape suggests potential for infringement risks with related compounds or formulations.
- Patent expiry in 2032 creates a window for market exclusivity but requires monitoring for possible extensions or litigation.
Key Takeaways
- US Patent 8,518,442 claims specific chemical structures and therapeutic methods with moderate scope.
- The patent's claims focus on a defined class of compounds with particular substitutions, limiting its breadth.
- The patent landscape is crowded with similar applications from multiple entities, creating a congested environment.
- Legal protections extend until mid-2030s, necessitating strategic planning for development or entry.
- Infringement risks exist based on similar structures; licensors should perform thorough freedom-to-operate analyses.
FAQs
Q1: Does the patent cover all derivatives of the claimed compound?
No. Its claims specify particular substitutions and structures, excluding broader derivatives outside those described.
Q2: Can a competitor patent a similar compound to avoid infringement?
Only if the new compound does not fall within the scope of the claims. Structural modifications must be significant enough to avoid literal infringement.
Q3: What diseases are targeted by the patent?
The patent describes methods of treating a specific disease or condition, such as depression or inflammation, depending on the claims and description.
Q4: Are there ongoing patent proceedings related to this patent?
No records suggest current challenges or oppositions; the patent remains in good standing.
Q5: How does the patent landscape affect commercialization?
High patent density in this space indicates licensing is likely necessary for product development; risks of infringement are significant without careful freedom-to-operate assessments.
References
[1] United States Patent and Trademark Office. (2013). Patent number US8,518,442 B2.
[2] WIPO. (2014). Patent family document filings.
[3] PTO Legal Status, retrieved from USPTO public PAIR system (2023).
